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Decreased Cardiac Glutathione Peroxidase Levels and
Enhanced Mandibular Apoptosis in Malformed Embryos
of Diabetic Rats
Parri Wentzel, Mattias Ga ¨reskog, and Ulf J. Eriksson
OBJECTIVE—To characterize normal and malformed embryos
within the same litters from control and diabetic rats for expres-
sion of genes related to metabolism of reactive oxygen species
(ROS) or glucose as well as developmental genes.
RESEARCH DESIGN AND METHODS—Embryos from non-
diabetic and streptozotocin-induced diabetic rats were collected
on gestational day 11 and evaluated for gene expression (PCR)
and distribution of activated caspase-3 and glutathione peroxi-
dase (Gpx)-1 by immunohistochemistry.
RESULTS—Maternal diabetes (MD group) caused growth
retardation and an increased malformation rate in the em-
bryos of MD group rats compared with those of controls (N
group). We found decreased gene expression of Gpx-1 and
increased expression of vascular endothelial growth factor-A
(Vegf-A) in malformed embryos of diabetic rats (MDm group)
compared with nonmalformed littermates (MDn group). Alter-
ations of messenger RNA levels of other genes were similar in
MDm and MDn embryos. Thus, expression of copper zinc
superoxide dismutase (CuZnSOD), manganese superoxide
dismutase (MnSOD), and sonic hedgehog homolog (Shh) were
decreased, and bone morphogenetic protein-4 (Bmp-4) was
increased, in the MD embryos compared with the N embryos.
In MDm embryos, we detected increased activated caspase-3
immunostaining in the ﬁrst visceral arch and cardiac area and
decreased Gpx-1 immunostaining in the cardiac tissue; both
ﬁndings differed from the caspase/Gpx-1 immunostaining of
the MDn and N embryos.
CONCLUSIONS—Maternal diabetes causes growth retardation,
congenital malformations, and decreased general antioxidative
gene expression in the embryo. In particular, enhanced apoptosis
of the ﬁrst visceral arch and heart, together with decreased
cardiac Gpx-1 levels, may compromise the mandible and heart
and thus cause an increased risk of developing congenital
malformation. Diabetes 57:3344–3352, 2008
T
he cellular and molecular mechanisms of dia-
betic embryopathy are not completely clear.
Previous experimental studies have suggested
that the teratological impact of a diabetic envi-
ronment partly depends on excess of reactive oxygen
species (ROS) in the embryo (1) as a consequence of
either increased free oxygen radical formation (2–4),
decreased capacity of ROS-scavenging enzymes (5–9), or
both. Furthermore, previous work has demonstrated that
supplementation of antioxidative agents such as copper
zinc superoxide dismutase (CuZnSOD) (1,2), N-acetylcys-
teine (10), vitamins E and C (8), and folic acid (11) in vitro,
as well as butylated hydroxytoluene (12), vitamin E (13–
19), vitamin C (18,20), N-acetylcysteine (21), and folic acid
(11) in vivo, attenuate malformation rate and diminish
markers of oxidative stress (e.g., by normalizing tissue
levels of thiobarbituric acid reactive substances [15], iso-
prostane 8-iso-PGF2 [22,23], and carbonylated proteins
[24]).
The driving cellular force behind diabetes-induced oxi-
dative stress is likely associated with enhanced glucose
metabolism (25–27) in the embryonic/fetal cells exposed
to increased ambient levels of glucose. One putative
primary source of reactive radical compounds is mito-
chondria receiving a high inﬂux of pyruvate and oxygen
and, subsequently, producing a large amount of ROS
(mainly superoxide) (3) in the oxidative processes of the
electron transport chain. The ensuing leakage of superox-
ide into other compartments of the mitochondria and the
cytosol, and the further formation of hydrogen peroxide
and hydroxyl radicals, should yield mitochondrial alter-
ations (28) as well as lipid peroxidation (22) and DNA
damage (29) in the embryo. There are several observations
in support of this notion. The structural alterations, mainly
high-amplitude swelling of the embryonic mitochondria
(28), are diminished by maternal antioxidative treatment
(16), thereby supporting the notion of a ROS-related
etiology of the structural changes. Enhanced lipid peroxi-
dation, as evidenced by increased levels of the isoprostane
8-iso-PGF2 (22,23,30), may induce several teratogenic
pathways in addition to the developmental disturbance
caused by peroxidation of structural lipids in mitochon-
drial and cellular membranes. For instance, it has been
demonstrated that 8-iso-PGF2, which is produced nonen-
zymatically by ROS-mediated oxidation of arachidonic
acid in the offspring (30), has its own teratogenic potency
(23). In addition, an excessive peroxidation of arachidonic
acid may hamper prostaglandin biosynthesis by depleting
precursor pools and, in particular, yield decreased concen-
tration of prostaglandin E2 (31), which could obstruct
neural tube closure (22).
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development via altered expression of key genes. In
addition, cellular DNA repair processes may activate
poly(ADP-ribose) polymerase (PARP), which may cause
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
inhibition by poly(ADP-ribosylation) (32). The net result
would be diminished embryonic GAPDH activity, which
has been demonstrated in rat embryos subjected to
diabetes in vivo and high glucose in vitro (33). Further-
more, decreased glycolytic ﬂux proximal to GAPDH (32)
and the presence of increased ambient glucose levels
will yield enhanced ﬂux in the polyol (34,35) and
hexosamine (36) pathways. An increased availability of
proximalglycolyticintermediarieswouldincreasediacyl-
glycerol production and cause activation of several
protein kinase C isoforms (37,38), as well as enhance
the ﬂux in the advanced glycosylation end product
pathway (39). All of the consequences of inhibited
GAPDH activity may thus contribute to the teratogenic
outcome of diabetic pregnancy. Evidently, there are
multiple ways for a diabetes-induced state of oxidative
stress in the embryo to disturb embryonic/fetal devel-
opment, several of which enjoy considerable experi-
mental support.
Another consequence of a state of oxidative stress
would be enhanced apoptosis in embryonic/fetal tissue
(40), which has been described (26,41–43) and has been
suggested to be mediated by enhanced Jun-amino-terminal
kinase-1 and -2 activity (19,44). It has also been suggested
that maternal diabetes induces an inﬂammatory state in
the embryo, where proinﬂammatory cytokines (i.e., tumor
necrosis factor- [TNF-] [45,46]) act to downregulate the
principal ROS-scavenging enzymes via increased activity
of mitogen-activated protein kinases (47). The exact rela-
tion between enhanced apoptosis and induction of malfor-
mations is still unclear, mainly since we do not fully
comprehend the speciﬁc transmission of a general in-
crease in programmed cell death into precisely restricted
developmental damage to embryonic organs or organ
systems (42).
Based on earlier studies (7,48,49) and on a question
that has been raised several times—which genes are
involved in diabetes-induced embryonic dysmorphogen-
esis? (5,8,26,42,50)—we wanted to add to the teratological
knowledge by identifying differences in gene expression
between the malformed and nonmalformed offspring
within the same litters of diabetic animals.
Our working hypothesis was that genes of the mal-
formed offspring with an expression pattern different from
that of genes in the nonmalformed offspring within the
same litter may be associated, either directly or indirectly,
with the teratogenic process. We thus decided to compare
gene expression of embryos that were morphologically
normal and those that were malformed in litters of normal
and diabetic rats. By comparing gene expression and
protein distribution in embryos of the same age and with
exposure to an identical intrauterine milieu, we aimed to
control for possible confounding factors of the teratogenic
process. From earlier work, we knew that the two tissues
of the rat fetuses that are particularly vulnerable to the
diabetic state are the mandible and the heart (17) (Fig. 1).
We also knew that a susceptible period in diabetic rat
pregnancy occurs during gestational days 6–10 (51), which
corresponds to weeks 2–4 in human pregnancy. Bearing in
mind that the size and relative immaturity of day-10
embryos makes them difﬁcult to evaluate for developmen-
tal defects, we chose to interrupt the rat pregnancies
on gestational day 11 in order to be able to clearly
distinguish between malformed and nonmalformed em-
bryos. We decided to relate embryonic (mal)development
to expression of the major oxidative defense genes (SODs,
glutathione peroxidase [Gpx]-1, Gpx-2, and catalase),
to key genes of glucose metabolism (aldose reductase
[AR] and GAPDH), to developmental/teratological genes
[poly(ADP-ribose) polymerase (PARP)], to tumor protein
53 (p53), to bone morphogenetic protein-4 (Bmp-4), to Ret
proto-oncogene (Ret), to sonic hedgehog homolog (Shh),
to vascular endothelial growth factor-A (VEGF-A), to
TNF-, to interleukin-6 (IL-6), and to the tissue distribu-
tion of activated caspase-3 (denoting apoptotic rate) and
Gpx-1.
RESEARCH DESIGN AND METHODS
Nondiabetic and diabetic rats from a local Sprague-Dawley strain (bred in the
animal facility of the Biomedical Center of Uppsala University) with an
increased incidence of congenital malformations in diabetic pregnancy were
used as embryo donors (12). The rats had free access to food (AB Analycen,
Lidko ¨ping, Sweden) and tap water and were maintained at an ambient
temperature of 22°C with a 12-h light/dark cycle.
Diabetes was induced with a single injection of 40 mg/kg streptozotocin
(STZ) (Sigma-Aldrich Chemie, Stenheim, Germany) into a tail vein (12). Within
1 week after STZ injection, blood glucose concentration was measured with a
Free Style Mini Glucose Meter (Thera Sense, Alameda, CA). Rats with a
glucose concentration 20 mmol/l were considered to be manifestly diabetic
(MD group), and female rats without STZ-induced diabetes were denoted as
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FIG. 1. A: Fetuses displaying micrognathia (left fetus) and normal morphology (right fetus). B: Outcome of pregnancy in the control (N) and
manifestly diabetic (MD) groups, distributed as normal (e), malformed (f), and resorbed (o) embryos on gestational day 11. *P < 0.05 vs. N (
2
statistics). (Please see http://dx.doi.org/10.2337/db08-0830 for a high-quality digital representation of this ﬁgure.)
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N rats were mated overnight with nondiabetic male rats. A positive vaginal
smear (containing sperm) the following morning designated gestational day 0.
On gestational day 11, the MD and N rats were killed by cervical dislocation
after light ether anesthesia. This gestational day was chosen because it
corresponds with an early stage of embryogenesis during which malforma-
tions of the heart, neural tube, and general rotation pattern can be identiﬁed
and, consequently, their severity can be assessed. The embryos were dissected
and evaluated with regard to presence of malformations (cardiac hypertrophy,
neural tube defects, and somatic malrotation), crown rump length, and somite
number. Viability of the embryos was conﬁrmed by the presence of a
heartbeat. Embryos were prepared for immunostaining (four N and four MD
litters) and gene expression determination (four N and ﬁve MD litters).
Preparation of total RNA. Total RNA from each embryo was isolated with
an RNeasy mini kit (Qiagen, Hilden, Germany), according to the manufactur-
er’s instructions. Brieﬂy, each embryo was lysed in 350 l buffer. The samples
were DNase treated (RNase-free DNase; Qiagen) and incubated at room
temperature for 25 min. The isolated total RNA was washed twice with 50 l
RNase-free water, and the accumulated ﬂow-through was collected, yielding
the total RNA sample. Lastly, 1 l of an RNase inhibitor (RNA Guard;
Amersham Pharmacia, Uppsala, Sweden) was added to each sample.
Preparation of complementary DNA. One microgram of total RNA was
used for complementary DNA (cDNA) preparation. For cDNA synthesis, we
used ﬁrst-strand beads (Ready To Go; Amersham Pharmacia Biotech), accord-
ing to the manufacturer’s instructions. The resulting cDNA was diluted
threefold with RNase-free water.
Analysis of messenger RNA levels. Four litters with 32 embryos yielded the
messenger RNA (mRNA) samples of the N group, whereas ﬁve litters with 35
embryos produced the mRNA samples of the MD group. One microliter of
cDNA puriﬁed from each embryo with 10 ng of converted total RNA was
ampliﬁed and measured in duplicate with real-time PCR using the MiniOpticon
system (Bio-Rad Laboratories, Hercules, CA), with SYBR green used to detect
the PCR product. Speciﬁc primers for CuZnSOD, MnSOD, Gpx-1, Gpx-2,
catalase, AR, GAPDH, p53, PARP, Shh, Ret, Bmp-4, VEGF-A, TNF-, and IL-6
were constructed with the aid of the Primer3 free software (available at
http://primer3.sourceforge.net/) and subsequently purchased from TIB Mol-
biol (Berlin, Germany) (Table 1). We have previously assessed the stability of
expression of various housekeeping genes and found the glucose-6-phosphate
dehydrogenase (G6PDH) gene to be constant in day-10 and day-11 embryos
exposed to high glucose in vitro or diabetes in vivo (data not shown);
therefore, we chose the G6PDH gene as a reference in the real-time PCR
protocol.
Controls were included in each run of the real-time PCR assay; for each
primer pair, one sample with no cDNA (with only RNase-free water) was
included. To exclude the possibility of remaining DNA fragments being
present in the samples, 10 ng of the total RNA of each sample was ampliﬁed
in the LightCycler. We found no PCR product in the water or the total RNA
samples. Furthermore, we excluded the avian myoblastosis virus-RT enzyme
in the cDNA preparation and found no ampliﬁed PCR product.
Results were analyzed for each sample with relative quantiﬁcation com-
paring the difference between sample and reference crossing point (Cp)
values. The relative abundance of mRNA/G6PDH in each sample was deter-
mined using the following equation to yield the ratio sample to G6PDH:
2
(Cp, sample  Cp, G6PDH)
Immunohistochemistry of activated (cleaved) caspase-3 and Gpx-1.
Thirty-ﬁve embryos from four litters and 28 embryos from four litters were
used for immunohistochemistry in the N and MD groups, respectively.
Embryos from different rats were ﬁxed in 4% paraformaldehyde for 24 h and
stored in 70% ethanol before they were embedded in parafﬁn and sectioned in
5-m-thick sections. The slides were deparafﬁnized and rehydrated in accor-
dance with standard procedures. Primary antibody; cleaved caspase-3; asp
175, 1:50 (1.2 g); or Gpx-1, 1:25 (2.5 g) (Cell Signaling Technology, Beverly,
MA) were applied. The slides were incubated with secondary antibody (Dako
EnVisionPeroxidase, goat anti-rabbit; Dako, Glostrup, Denmark). Thereaf-
ter, the slides were incubated with chromogenic substrate solution Sigma Fast
3,3-diaminobenzidine tablet sets (Sigma-Aldrich Chemie). Lastly, the slides
were counterstained (Mayer hematoxylin; Histolab, Gothenburg, Sweden) and
mounted with coverslips. The slides were viewed and photographed in a Leitz
DMRB Leica ﬂuorescence microscope (Leica, Stockholm, Sweden).
Statistical and ethical considerations. The Uppsala Regional Ethical
Committee on Animal Experiments approved the research protocol, including
all experimental procedures involving animals. The comparisons between
different experimental groups were based on individual embryos. Differences
between means were evaluated by Student’s two-tailed t test as well as by
ANOVA with Fisher’s protected least signiﬁcant difference as a post hoc test.
The rates of normal embryos and embryos with malformations were com-
pared with 
2 statistics. A value of P  0.05 was considered to denote a
statistically signiﬁcant difference between groups. The calculations were
performed with the aid of the Macintosh version of the statistical program
Statview.
RESULTS
Maternal diabetes increased malformation and resorption
rates in embryos of diabetic pregnancy compared with
embryos of normal pregnancy (Fig. 1). We also found
decreased crown rump length as well as diminished
TABLE 2
Crown rump length and somite number in embryos of control (N
group) and manifestly diabetic (MD group) rats
n
Crown rump
length (mm) Somites
N group (normal) 66 3.85 	 0.03 29.8 	 0.2
N group (malformed) 1 1.50 17.0
MD group (normal) 36 2.95 	 0.07* 25.7 	 0.3*
MD group (malformed) 27 2.20 	 0.11*† 15.8 	 1.2*†
Data are means 	 SE. The N and MD offspring are also subdivided
into nonmalformed (N/MD normal) and malformed (N/MD mal-
formed). *P  0.05 vs. N and †P  0.05 vs. N/MD normal (Student’s
t test).
TABLE 1
Primers used in the study
Gene Forward primer Reverse primer
G6PDH gTCATgCAgAACCACCTCCT ACATACTggCCAAggACCAC
CuZnSOD AAgCggTgAACCAgTTgTg CCAggTCTCCAACATgCC
MnSOD ggTggAgAACCCAAAggAgA AgCAgTggAATAAggCCTgT
Gpx-1 TgAgAAgTgCgAggTgAATg AACACCgTCTggACCTACCA
Gpx-2 TgCCCTACCCTTATgACgAC ggAgATTCCTAggCTgAgCA
Catalase TTATgTTACCTCACAgCCTggT gTgTTgTgTgTTCTgTgTgTgTAg
Aldose reductase CgCCAggATCTCTTCATTgT CTCCATAgCCgTCCAAgTgT
GAPDH ggCATTgCTCTCAATgACAA TgTgAgggAgATgCTCAgTg
PARP CTggACAACCTCCTggACAT CgCgTgAgTgTTCTTCACAT
p53 CCCTgAAgACTggATAACTgTCAT CTCAgTTCCAggTTCCTgTg
Shh TTAAATgCCTTggCCATCTC TTTCACAgAgCAgTggATgC
Ret CTggAgCCAACAAggAgAAg CCACATCTgCATCAAACACC
Bmp-4 CgTTACCTCAAgggAgTggA AgTCCACgTAgAgCgAATgg
VEGF-A gCCCTgAgTCAAgAggACAg CAggCTCCTgATTCTTCCAg
TNF- ggCATggATCTCAAAgACAACC gAggCTgACTTTCTCCTggTAT
IL-6 TgATggATgCTTCCAAACTg gAgCATTggAAgTTggggTA
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with embryos from nondiabetic rats (Table 2).
The expression patterns of the antioxidative enzymes
(AOEs) are shown in Fig. 2. We found decreased gene
expression of CuZnSOD, MnSOD, and Gpx-1 in MD em-
bryos (both nonmalformed embryos of STZ-induced dia-
betic rats [MDn group] and malformed littermates [MDm
group]) compared with N embryos. In addition, Gpx-1
mRNA levels were more decreased in MDm than in MDn
embryos, and Gpx-2 and catalase expression did not differ
between the groups (Fig. 2). No signiﬁcant differences
were found with regard to gene expression of AR, GAPDH,
p53, and PARP (Fig. 3).
Shh was decreased, Ret was unaltered, and Bmp-4
mRNA levels were increased in MD embryos compared
with N embryos (Fig. 4). VEGF-A mRNA levels were
increased in both the MDn and MDm embryos compared
with N embryos, and, in addition, the MDm embryos had
higher mRNA levels than the MDn embryos (Fig. 4). The
TNF- mRNA levels were decreased in the MD embryos
(Fig. 4), whereas we could not demonstrate IL-6 mRNA in
the embryos (data not shown).
We detected increased activated caspase-3 immuno-
staining in the ﬁrst visceral arch and cardiac area in the
MDm embryos compared with the MDn and N embryos
(Fig. 5). The immunostaining of Gpx-1 displayed a general
accumulation of positive cells in the cardiac tissue of all
embryos; however, the MDn embryos had less staining
than the N embryos, and the MDm embryos had less
staining than the MDn embryos (Fig. 6).
DISCUSSION
One important ﬁnding in the present study was that
maternal diabetes diminishes the antioxidative defense
gene expression in the embryos, as evidenced by de-
creased expression of CuZnSOD, MnSOD, and Gpx-1 in
MDn and MDm offspring, which may be responsible for a
decrease in AOE activity (52). This observation is in
concert with previous reports (7–9,48) of diminished AOE
activity in embryonic tissues exposed to diabetes; how-
ever, it is not in concert with all previous reports (2,7,9),
which may be related to differences in mode and time of
exposure to the diabetes milieu. In addition, in the present
study we detected decreased Gpx-1 mRNA levels in MDm
embryos and a corresponding reduction of Gpx-1 protein
in the cardiac tissues of the MDm embryos, both ﬁndings
differing from MDn embryos of the same litters, as well as
from Gpx-1 estimations in N embryos. In a similar rat
model, Gpx activity was found decreased in embryos with
CuZnSOD
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FIG. 2. Gene expression of CuZnSOD, MnSOD, Gpx-1, Gpx-2, and catalase on gestational day 11 in the control (N) and manifestly diabetic (MD)
groups containing 29 and 32 embryos, respectively. Nonmalformed and malformed N and MD offspring are denoted Nn (28 embryos), MDn (20
embryos), Nm (1 embryo), and MDm (12 embryos), respectively. Data are means  SE. *P < 0.05 vs. N and #P < 0.05 vs. MDn (ANOVA).
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bryos from the same litters of diabetic rats (7).
The speciﬁc decrease in Gpx-1 expression/occurrence
in MDm embryos may suggest an association between the
abundance of this isoform of glutathione peroxidase and
the teratogenicity of diabetes, tentatively, with the pro-
cesses behind cardiac malformations. Such an association
has not been suggested before, to our knowledge, and the
localization of Gpx-1 protein in the cardiac wall on day 11
may suggest the occurrence of a protective antioxidative
mechanism. The net effect of the Gpx-1 deﬁciency (further
enhanced by the decreased levels of the other AOEs)
would be enhanced cellular damage, as suggested by mice
with a targeted Gpx-1 mutation; they display mitochon-
drial dysfunction (53) and apoptosis (54)—changes that
are in line with a teratological disturbance of normal
development. Evidently, however, the association be-
tween malformation and reduced Gpx-1 expression may
also be the opposite; the embryonic maldevelopment may
actually induce the alteration in Gpx-1 mRNA levels and,
putatively, decreased activity of the enzyme (7).
In previous work, we have only been able to secure
suggestive evidence of enhanced regional apoptotic activ-
ity in embryos subjected to a diabetic environment. We
thus regard the results of the immunohistochemistry ef-
forts of the present study with great interest. We thus
found increased caspase-3 immunostaining, in the ﬁrst
visceral arch and in cardiac tissue of the MDm embryos
compared with that of MDn and N embryos, indicative of
enhanced apoptosis in the two regions corresponding to
the two major types of diabetes-induced malformations
in this rat model, micrognathia and cardiac outﬂow de-
fects (Figure 1).
We found only one malformed N embryo, which dis-
played gene expression patterns similar to the MDm
embryos, further supporting the view that generalized
changes of the gene clusters pave the way for speciﬁc
morphogenetic alterations. In particular, the SODs, Gpx-1,
and Shh genes decreased and VEGF increased in the Nm
embryo, thus indicating a coupling to oxidative stress and
neural crest cell development. However, the small sample
size (n 
 1) precludes any far-reaching conclusions.
The effect on AOE gene expression was strikingly
similar in CuZnSOD, MnSOD, and Gpx-1, which were all
decreased. The ﬁnding of these diabetes-related genes
suggests, in concert with previous studies (4,5,7,9), that
maternal diabetes causes a general downregulation of the
principal AOEs in rat embryos prone to develop congenital
malformations and allows the speculation that this puta-
tive weakening of the antioxidative defense may be in-
volved in the teratogenic process. The physiological
reasons for diminished ROS-scavenging gene expression
in the diabetes-exposed embryos are not clear and may,
therefore, currently be subject to speculation only. It is
noteworthy that in the present study, we found decreased
TNF- mRNA levels and could not detect IL-6 in the
embryos; therefore, a “generalized inﬂammation” causing
the diminished AOE gene expression does not seem to be
likely, at least not at this embryonic stage (45,46).
The metabolic state of the severely STZ-induced dia-
betic non–insulin-treated rat has been characterized pre-
viously by us (10,25). In general, the diabetic state yields
blood glucose levels in the range of 20–25 mmol/l, as well
as increased concentrations of ketone bodies (10) and
increased levels of branched chain amino acids (25). The
particular characteristics of the diabetic state, which may
be primarily affecting gene expression, are not clear, but
increased glucose levels should be of importance because
in vitro exposure of embryos to high glucose levels pro-
motes gene expression changes analogous to those found
in vivo. Furthermore, existence of a functioning glucose
transporter gene has been shown to be of fundamental
importance for diabetes-induced embryonic (mal)develop-
ment (27), illustrating the importance of high intracellular
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FIG. 3. Gene expression of aldose reductase (AR), GAPDH, p53, and PARP on gestational day 11 in the control (N) and manifestly diabetic (MD)
groups containing 29 and 32 embryos, respectively. Nonmalformed and malformed N and MD offspring are denoted Nn (28 embryos), MDn (20
embryos), Nm (1 embryo), and MDm (12 embryos), respectively. Data are means  SE.
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genes controlling glucose metabolism, we and others have
previously identiﬁed an association between increased
sorbitol accumulation and dysmorphogenesis in the em-
bryo (34,35). However, attempting to diminish such accu-
mulation by using aldose reductase inhibitors did not
prevent the maldevelopment in the offspring (34,35).
Another reason for the interest in the AR and GAPDH
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FIG. 4. Gene expression of Shh, Ret, Bmp-4, VEGF-A, and TNF- on gestational day 11 in the control (N) and manifestly diabetic (MD) groups
containing 29 and 32 embryos, respectively. Nonmalformed and malformed N and MD offspring are denoted Nn (28 embryos), MDn (20 embryos),
Nm (1 embryo), and MDm (12 embryos), respectively. Data are means  SE. *P < 0.05 vs. N and #P < 0.05 vs. MDn (ANOVA).
FIG. 5. Distribution of activated caspase-3 protein in nonmalformed N embryo (A), nonmalformed MD embryo (B), and malformed MD embryo
(C). The ﬁrst visceral arch (square) and cardiac area (circle) are marked. Note differences in caspase-3 staining between the embryos. Space
bar  400 m. (Please see http://dx.doi.org/10.2337/db08-0830 for a high-quality digital representation of this ﬁgure.)
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diabetic rats, in which we found linkage to the chromo-
somal regions harboring these two genes (U.J.E., N. Nor-
dquist, H. Luthman, U. Pettersson, unpublished data). In
the present study, however, we found no signiﬁcant
changes of mRNA levels of AR and GAPDH in the MD
embryos, as noted previously with regard to the GAPDH
expression (33), a difference we are unable to explain. The
previously demonstrated diabetes-induced decrease in
GAPDH enzyme activity (33) may thus be a ROS-mediated
alteration of the GAPDH enzyme itself (either directly or
via DNA damage–induced PARP activity) (32), thereby
causing a block in the glycolytic pathway with a number of
metabolic effects with teratological importance, such as
diacylglycerol-mediated activation of (several isoforms of)
protein kinase C (37,38), increased hexosamine ﬂux (36),
and enhanced production of glycosylation precursors/
products (39).
Maternal diabetes did not alter embryonic p53 (as noted
previously [43]) and PARP expression in the present study,
despite a putative PARP activity increase due to the
presence of DNA damage in the MD embryos (29). The
increased Bmp-4 levels of the embryos of STZ-induced
diabetic rats suggested speciﬁc affection of the precursors
of the skeletal system, which backs earlier ﬁndings of
delayed and defective chondrogenesis and osteogenesis in
the offspring (55).
With regard to the diabetes-induced malformations of
this rat model (Fig. 1), suggested to have a neural crest
cell-derived origin (17), the two neural crest-associated
genes, Shh and Ret, were expected to be affected. Whereas
the Ret gene was unaltered by maternal diabetes, we found
a diabetes-induced decrease in the Shh mRNA levels in the
MD embryos. Despite the absence of a signiﬁcant differ-
ence in Shh mRNA levels between the MDn and MDm
embryos, the decreased Shh expression in the MD off-
spring is of particular interest in relation to the ﬁndings of
embryonic craniofacial (56) and aortic (57) anomalies
resulting from direct inhibition of Shh, as well as the
ﬁndings of an early role for Shh in securing the neural
crest cell survival in the early development of the lower
jaw (58). Taken together, these results support a diabetes-
induced disturbance in the neural crest cell development
(17,59) of the embryos of the present model and, puta-
tively, in human diabetic pregnancy as well. However,
since isolated neural stem cells exposed to glucose in vitro
show increased gene expression of both Shh and Bmp-4
(50), the exact relationship(s) between gene expression
changes in the surrounding tissues and the neural crest
cells themselves caused by exposure to a diabetic environ-
ment will have be subject to further studies.
We found markedly increased VEGF-A expression in the
MD embryos and further increased expression in the
malformed embryos compared with the nonmalformed
MD embryos. This is of particular interest with regard to
the coupling between VEGF alterations and hampered
embryonic development (60), although an increased VEGF
expression has not been previously reported in association
with embryonic dysmorphogenesis. We suggest that the
enhanced embryonic VEGF-A levels in the present study
may be interpreted as a compensatory change in response
to a diabetes-induced general developmental delay. The
demonstrated gene expression changes in malformed (and
nonmalformed) embryos of diabetic rats will evidently
demand future work efforts in order to clarify the associ-
ation to embryonic maldevelopment (cause, effect, or no
relation at all—efforts that, to some extent, are ongoing.
One major, and slightly surprising, observation was that
there was no clear individual pattern of gene expression in
the embryos for any of the genes studied (online appendix
[available at http://dx.doi.org/10.2337/db08-0830]). Thus,
when examining individual gene expression values, there
was no evident relation to uterine position, growth, or
morphological status (with the possible exceptions of
Gpx-1 and Vegf-A). The Gpx-1 mRNA was markedly
decreased and the VEGF-A mRNA was markedly in-
creased in malformed compared with nonmalformed em-
bryos from the same litter of diabetic rats. Further efforts
FIG. 6. Distribution of Gpx-1 protein in whole embryo (A–C) and ﬁrst visceral arch (D–F). A and D: Shows an N embryo. B and E: Shows a
nonmalformed MD embryo. C and F: Shows a malformed MD embryo. Note differences in staining of cardiac area. (Please see http://dx.doi.org/
10.2337/db08-0830 for a high-quality digital representation of this ﬁgure.)
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ital malformations may therefore beneﬁt from considering
a putative impact of a decrease in embryonic Gpx-1
expression and, possibly, function as well as considering
the importance of enhanced VEGF-A expression for em-
bryonic development.
We conclude that maternal diabetes causes growth
retardation, congenital malformations, and decreased gen-
eral antioxidative gene expression in the embryo. In
particular, enhanced apoptosis of the ﬁrst visceral arch
and heart, together with decreased cardiac Gpx-1 levels,
may cause the mandible and heart to have an increased
risk of developing congenital malformation.
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